The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients

Acute Retinal Necrosis Clinical Trial

Official title:

The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03260049
• Other study ID #: ChongqingMU-2
• Status: Completed
• Phase: N/A
• First received: August 21, 2017
• Last updated: August 21, 2017
• Start date: April 2012
• Est. completion date: February 2017

Study information

• Verified date: August 2017
• Source: Chongqing Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The records of patients who were diagnosed with ARN between April 2010 and February 2017 were analyzed.A retrospective review of the treatment options and outcomes of the these patients was performed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: February 2017
• Est. primary completion date: February 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• ARN was diagnosed according to the American Uveitis Society Diagnostic Criteria (1994)

Exclusion Criteria:

Related Conditions & MeSH terms

• Acute Retinal Necrosis
• Necrosis

Intervention

Procedure:
• pars plana vitrectomy
pars plana vitrectomy

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Chongqing Medical University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	visual acuity		1 year
Secondary	retinal detachement		1 year